Trial Profile
An Open-Label Study to Evaluate "Completeness of Response" Following Treatment With Treximet for Migraine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary) ; Tryptamines
- Indications Migraine
- Focus Therapeutic Use
- 23 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jun 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 23 Jun 2010 Actual patient number (147) added as reported by ClinicalTrials.gov.